Every coffee keeps the site running. Thank you!
Tech, gaming and the news that matters
Phase II clinical trial results published this week indicate that drug candidates optimized entirely via computational biology platforms demonstrated target affinity comparable to traditionally synthesized molecules.
Capital Efficiency in R&D
Pharmaceutical leaders estimate that integrating generative protein structure prediction cuts target-to-lead development phases from 18 months down to under six months, fundamentally altering bio-R&D cost structures.
Pharmaceutical developers are leveraging continuous patient monitoring to improve trial retention and data fidelity.
Surging demand for metabolic therapies strains cold-chain logistics and forces supply chain network expansions.
Widespread adoption of anti-obesity medications alters consumer purchasing habits, impacting calorie-dense packaged goods revenues.
Medical device manufacturers secure regulatory approvals to offer continuous monitoring hardware to non-diabetic populations.
Once you’ve completely relaxed, and the mind is calm, bring to mind a being, or a force, that…
Many of us think that smartphone tendonitis is an imaginary condition but, we must tell you that it…